| 臺大學術典藏 |
2022-01-24T09:32:26Z |
Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients
|
CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Jeng Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:22Z |
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C
|
CHUN-JEN LIU; Jeng Y.-M.; Chen P.-J.; Lai M.-Y.; Yang H.-C.; Huang W.-L.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:20Z |
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
|
CHUN-JEN LIU; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; Yang W.-S.; Lai M.-Y.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:01Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
CHUN-JEN LIU; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:43Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; CHUN-JEN LIU; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:35Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; CHUN-JEN LIU; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:31:31Z |
Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
|
Li Y.-T.; CHUN-JEN LIU; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Wu H.-L. |
| 臺大學術典藏 |
2022-01-24T06:05:35Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; CHIUN HSU; Hsieh C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-01-20T07:58:02Z |
The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma
|
Chang H.-H.; Lu M.-Y.; Yang Y.-L.; SHU-WEI CHOU; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Jeng Y.-M.; Jou S.-T. |
| 臺大學術典藏 |
2022-01-20T07:58:01Z |
MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients
|
Chang H.-H.; Tseng Y.-F.; Lu M.-Y.; Yang Y.-L.; SHU-WEI CHOU; Lin D.-T.; Lin K.-H.; Jou S.-T.; Hsu W.-M.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-01-07T06:06:02Z |
Solid pseudopapillary neoplasms of the pancreas: Is there a pathologic basis for the observed gender differences in incidence?
|
Tien Y.-W.; Ser K.-H.; Hu R.-H.; CHIH-YUAN LEE; Jeng Y.-M.; Lee P.-H. |
| 臺大學術典藏 |
2022-01-07T06:05:48Z |
Human pancreatic afferent and efferent nerves: Mapping and 3-D illustration of exocrine, endocrine, and adipose innervation
|
Chien H.-J.; Chiang T.-C.; Peng S.-J.; Chung M.-H.; Chou Y.-H.; CHIH-YUAN LEE; Jeng Y.-M.; Tien Y.-W.; Tang S.-C. |
| 臺大學術典藏 |
2022-01-07T06:05:48Z |
Lymphatic vessel remodeling and invasion in pancreatic cancer progression
|
Shen C.-N.; Goh K.-S.; Huang C.-R.; Chiang T.-C.; CHIH-YUAN LEE; Jeng Y.-M.; Peng S.-J.; Chien H.-J.; Chung M.-H.; Chou Y.-H.; Hsieh C.-C.; Kulkarni S.; Pasricha P.J.; Tien Y.-W.; Tang S.-C. |
| 臺大學術典藏 |
2022-01-07T06:05:45Z |
Local islet remodelling associated with duct lesion–islet complex in adult human pancreas
|
Tien Y.-W.; Chien H.-J.; Chiang T.-C.; Chung M.-H.; CHIH-YUAN LEE; Peng S.-J.; Chen C.-C.; Chou Y.-H.; Hsiao F.-T.; Jeng Y.-M.; Tang S.-C. |
| 臺大學術典藏 |
2021-12-09T08:29:15Z |
Erratum: Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling (Oncogene (2012) 31 (2401-2411) DOI: 10.1038/onc.2011.423)
|
Yang, M. H.; Lin, B. R.; HSIN-CHIEH CHANG; Chen, S. T.; Lin, S. K.; Kuo, M. Y.P.; Jeng, Y. M.; Kuo, M. L.; Chang, C. C. |
| 臺大學術典藏 |
2021-10-27T03:22:25Z |
RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy
|
Tsai J.-H.; Liau J.-Y.; CHANG-TSU YUAN; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2021-10-27T03:22:24Z |
RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct
|
Tsai J.-H.; Liau J.-Y.; CHANG-TSU YUAN; Cheng M.-L.; Yuan R.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2021-10-27T03:22:20Z |
Traditional Serrated Pathway-Associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations
|
Tsai J.-H.; Jeng Y.-M.; CHANG-TSU YUAN; Lin Y.-L.; Cheng M.-L.; Liau J.-Y. |
| 臺大學術典藏 |
2021-10-27T03:22:19Z |
An Integrative Morphomolecular Classification System of Gastric Carcinoma with Distinct Clinical Outcomes
|
Tsai J.-H.; Jeng Y.-M.; Chen K.-H.; Lee C.-H.; CHANG-TSU YUAN; Liau J.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:31Z |
Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential
|
Wang C.-C.; CHAO-YUAN HUANG; Jhuang Y.-L.; Chen C.-C.; Jeng Y.-M. |
| 臺大學術典藏 |
2021-10-06T08:04:48Z |
Rapid Trio Exome Sequencing for Autosomal Recessive Renal Tubular Dysgenesis in Recurrent Oligohydramnios
|
Lin S.-Y.; Chuang G.-T.; Hung C.-H.; Lin W.-C.; Jeng Y.-M.; Yen T.-A.; Chang K.; Chien Y.-H.; Hwu W.-L.; Lee C.-N.; I-JUNG TSAI; Lee N.-C. |
| 臺大學術典藏 |
2021-09-27T02:17:57Z |
Rapid Trio Exome Sequencing for Autosomal Recessive Renal Tubular Dysgenesis in Recurrent Oligohydramnios
|
Lin S.-Y.; Chuang G.-T.; Hung C.-H.; Lin W.-C.; Jeng Y.-M.; Yen T.-A.; Chang K.; Chien Y.-H.; Hwu W.-L.|CHIEN-NAN LEE; Tsai I.-J.; Lee N.-C. |
| 臺大學術典藏 |
2021-09-15T01:20:49Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.; CHIA-LANG HSU; Jeng Y.-M.; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-15T01:20:49Z |
Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver
|
Ho T.-C.; Wang E.-Y.; Yeh K.-H.; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; CHIA-LANG HSU; Chen P.-J.; Yeh S.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-15T01:20:45Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
CHIA-LANG HSU; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; Cheng A.-L.; Jeng Y.-M.; Hsu C. |
| 臺大學術典藏 |
2021-09-04T06:19:11Z |
Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients
|
Liu C.-J.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Jeng Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:10Z |
Interferon-α reduces insulin resistance and β-cell secretion in responders among patients with chronic hepatitis B and C
|
Tai T.-Y.; Lu J.-Y.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; JIA-HORNG KAO; Lee C.-Z.; Lee H.-S.; Chuang L.-M.; Jeng Y.-M. |
| 臺大學術典藏 |
2021-09-04T06:19:07Z |
Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma
|
Ni Y.-H.; Chang M.-H.; Wang K.-J.; Hsu H.-Y.; Chen H.-L.; JIA-HORNG KAO; Yeh S.-H.; Jeng Y.-M.; Tsai K.-S.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:06Z |
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C
|
Liu C.-J.; Jeng Y.-M.; Chen P.-J.; Lai M.-Y.; Yang H.-C.; Huang W.-L.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:04Z |
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
|
Liu C.-J.; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; Yang W.-S.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:26Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
Liu C.-J.; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:43Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:11:20Z |
Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
|
Li Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.; Wu H.-L. |
| 臺大學術典藏 |
2021-09-04T05:16:56Z |
Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma
|
Liao S.-H.; Su T.-H.; Jeng Y.-M.; Liang P.-C.; Chen D.-S.; Chen C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:18Z |
Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma
|
Huang S.-C.; Liao S.-H.; Su T.-H.; Jeng Y.-M.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-01T02:02:25Z |
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age
|
Liang J.T.; Huang K.C.; ANN-LII CHENG; Jeng Y.M.; Wu M.S.; Wang S.M. |
| 臺大學術典藏 |
2021-09-01T02:02:10Z |
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms
|
Lien H.-C.; Lu Y.-S.; ANN-LII CHENG; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; Huang C.-S.; Chang K.-J.; Yao Y.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:23Z |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
|
Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:23Z |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:18Z |
Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway
|
Chou C.H.; Chen P.-J.; Jeng Y.-M.; ANN-LII CHENG; Huang L.-R.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:13Z |
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
|
Lin Z.-Z.; Jeng Y.-M.; Hu F.-C.; Pan H.-W.; Tsao H.-W.; Lai P.; Lee P.; ANN-LII CHENG; Hsu H.-C. |
| 臺大學術典藏 |
2021-08-31T06:42:25Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:22Z |
Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma
|
Lin Z.-Z.; Hsu C.; Jeng Y.-M.; Hu F.-C.; Pan H.-W.; Wu Y.-M.; Hsu H.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:19Z |
Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma
|
Shen Y.-C.; Hsu C.-L.; Jeng Y.-M.; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-20T02:45:41Z |
An Integrative Morphomolecular Classification System of Gastric Carcinoma with Distinct Clinical Outcomes
|
Tsai J.-H.; Jeng Y.-M.; KUO-HSING CHEN; Lee C.-H.; Yuan C.-T.; Liau J.-Y. |
| 臺大學術典藏 |
2021-08-12T04:01:28Z |
Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma
|
Chang M.-C.; Chang Y.-T.; Chen J.-Y.; Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; YANG SHIH-HUNG; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. |
| 臺大學術典藏 |
2021-08-12T04:01:26Z |
Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan
|
Chang M.-C.; Wu C.-H.; YANG SHIH-HUNG; Liang P.-C.; Chen B.-B.; Jan I.-S.; Chang Y.-T.; Jeng Y.-M. |
| 臺大學術典藏 |
2021-08-11T03:46:52Z |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
|
ZHONG-ZHE LIN; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:52Z |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; ZHONG-ZHE LIN; Chang M.-C.; Hsu C.; Cheng A.-L. |
